Sandoz

Trial and FDA signals

• FDA complete response letter Received an FDA complete response letter (BLA 761271, letter dated Dec 9, 2025). FDA BLA 761271 (Dec 9, 2025)
  Evidence (1 event)

  • Dec 9, 2025 · FDA BLA 761271
    CRL text (OCR, redacted by FDA; first 200 chars from "COMPLETE RESPONSE"): COMPLETE RESPONSE Sandoz Inc. Attention: Raheel Khan, MBA, RAC Associate Director, Global Regulatory Affairs Princeton, NJ (street omitted) Dear Raheel Khan: submission. We acknowledge rece

Job counts as of Oct 18, 2026. All trial and FDA signals